BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2458746)

  • 1. Bacteroides fragilis lipopolysaccharide and group B streptococcus serotype II glycocalyx have a common major antigenic determinant.
    Linko L; Viljanen MK
    APMIS; 1988 Sep; 96(9):805-12. PubMed ID: 2458746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the common immunodominant antigenic determinant in the lipopolysaccharide of Bacteroides fragilis by a monoclonal antibody.
    Linko L; Weintraub A; Arstila P; Pelliniemi LJ; Viljanen MK
    Scand J Immunol; 1987 May; 25(5):469-75. PubMed ID: 2438749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological markers of the R4 protein of Streptococcus agalactiae.
    Maeland JA; Bevanger L; Lyng RV
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1305-10. PubMed ID: 16275945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
    Pantosti A; Colangeli R; Tzianabos AO; Kasper DL
    J Clin Microbiol; 1995 Oct; 33(10):2647-52. PubMed ID: 8567899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.
    Kvam AI; Mavenyengwa RT; Radtke A; Maeland JA
    Clin Vaccine Immunol; 2011 Aug; 18(8):1365-70. PubMed ID: 21653744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Bacteroides ovatus in clinical specimens by immunofluorescence with a monoclonal antibody to B. fragilis lipopolysaccharide.
    Viljanen MK; Linko L; Lehtonen OP
    J Clin Microbiol; 1988 Mar; 26(3):448-52. PubMed ID: 3281973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of the serotype b and species-specific antigens of Actinobacillus actinobacillus actinomycetemcomitans recognized by monoclonal antibodies.
    McArthur WP; Stroup S; McClellan S; Leung KP
    Oral Microbiol Immunol; 1996 Aug; 11(4):209-19. PubMed ID: 9002872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsular and 'O' serotype determinants of bacteroides fragilis.
    Tabaqchali S; Fiddian PA; El-Hag K; Kasper DL
    Infection; 1982; 10(6):333-7. PubMed ID: 6185437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide.
    Linko-Kettunen L; Arstila P; Jalkanen M; Jousimies-Somer H; Lassila O; Lehtonen OP; Weintraub A; Viljanen MK
    J Clin Microbiol; 1984 Sep; 20(3):519-24. PubMed ID: 6386867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of a species specific determinant of Bacteroides fragilis lipopolysaccharides using monoclonal antibodies].
    Schulz TF; Brake BA; Sperzel M; Kofler J; Dierich MP
    Wien Klin Wochenschr; 1985 Mar; 97(5):237-9. PubMed ID: 2581371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and partial characterization of monoclonal antibodies to Pasteurella haemolytica A1 capsular polysaccharide and lipopolysaccharide.
    Penaredondo MV; Maheswaran SK; Whiteley LO; Ames TR; Leininger JR
    Am J Vet Res; 1988 Nov; 49(11):1962-8. PubMed ID: 2470277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic determinants of alpha-like proteins of Streptococcus agalactiae.
    Maeland JA; Bevanger L; Lyng RV
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1035-9. PubMed ID: 15539502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic properties of LPS extracted from Bacteroides fragilis enterotoxin producing strains.
    Meisel-Mikołajczyk F; Kot K; Kłos W; Rouyan GS; Mieszała M; Gamian A
    Acta Microbiol Pol; 1999; 48(2):153-61. PubMed ID: 10581671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity of Bacteroides fragilis O antigens.
    Hofstad T
    Acta Pathol Microbiol Scand B; 1977 Feb; 85B(1):9-13. PubMed ID: 65902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of group B streptococcal antigen by monoclonal antibody sandwich enzyme assay.
    Morrow DL; Kline JB; Douglas SD; Polin RA
    J Clin Microbiol; 1984 Apr; 19(4):457-9. PubMed ID: 6371047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological detection of Bacteroides fragilis in clinical samples.
    Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
    J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody.
    Reid JH; Patrick S; Tabaqchali S
    J Gen Microbiol; 1987 Jan; 133(1):171-9. PubMed ID: 3309142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Bacteroides fragilis by indirect immunofluorescence.
    Weintraub A; Lindberg AA; Nord CE
    Med Microbiol Immunol; 1979; 167(4):223-30. PubMed ID: 94651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of monoclonal antibodies in serovar classification of group B streptococci (GBS). Brief report.
    Naess AI; Bevanger L; Iversen OJ; Maeland JA
    APMIS; 1991 Nov; 99(11):1058-60. PubMed ID: 1958351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.